The F4/80+ TAMs present in these tumours represented 10.8 ± 3.3% of all live tumoural cells (Fig. 1c) and expressed FAP, alongside the macrophage/TAM markers CCR2, CD11b, CD14, MHCII, IL4-R and MMR, with a low expression of the dendritic cell marker CD11c (Fig. 1d and Supplementary Figure 1b). Here, ITGAX is linked to neoplasm.